• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. The safety and therapeutic efficacy evaluation for UCMSCs transplantation combined with plasma excha

The safety and therapeutic efficacy evaluation for UCMSCs transplantation combined with plasma excha

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：konlee53
【摘 要】
：
Background:Although previous studies showed that MSCs was a novel and promising treatment method and plasma exchange was also an effective therapy method for liver failure,there were still many proble
【作 者】
：
HL He WX Xu JG Li H Deng GL Lin ZL Gao 
【机 构】
：
Department of Infectious Diseases,Affiliated Provincial Hospital of Anhui Medical University,Hefei,A
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Although previous studies showed that MSCs was a novel and promising treatment method and plasma exchange was also an effective therapy method for liver failure,there were still many problems in both.In this study,to evaluate the safety and therapeutic efficacy of human umbilical cord mesenchymal stem cells(UCMSCs)transplantation combined with plasma exchange(PE) for patients with liver failure caused by HBV.
其他文献
Incidence and determinants of HBsAg seroclearance and HBeAg seroconversion:a community-based follow-
Background:Seroclearance of HBsAg and HBeAg seroconversion are the important events in the natural history of the HBV infection.However,the spontaneous rates of HBsAg seroclearance,HBsAg seroconverion
会议
Elevated expression of chemokine CXCL13 in chronic hepatitis B patients links to immune control duri
Background:C-X-C-chemokine ligand 13(CXCL13),the ligand for C-X-C chemokine receptor type 5(CXCR5),is a major regulator of B-cell trafficking and plays an integral role in age-dependent clearance of H
会议
Predictors of the complete virologic response in na(i)ve chronic hepatitis B patients with entecavir
Background:We assessed baseline and on-treatment variables to determine predictive factors of the complete virologic response in na(i)ve chronic hepatitis B patients with entecavir therapy.
会议
Added value of new biomarkers over the aspartate aminotransferase-to-platelet ratio index for the pr
Background:The aspartate aminotransferase-to-platelet ratio index(APRI) has the advantage of including only two inexpensive routine laboratory tests and widespread availability,but it does not directl
会议
A PROSPECTIVE RANDOMIZED COMPARISON OF 5YEARS TREATMENT EFFICACY BETWEEN ENTECAVIR AND ADEFOVIR IN T
Background:Entecavir(ETV) and adefovir(ADV) had been considered as first line treatment of Chronic hepatitis B(CHB).But there are little prospective data comparing long term efficacy and safety of bot
会议
Serum level of microRNA in the chronic Hepatitis B have the relationship with liver failure
Background:To demonstrate whether miRNA in serum can serve as molecular markers to failure(LF) whether predict the long-term prognosis of patients.
会议
Low Caloric Intake and Graft Function in the Early Period after Liver Transplantation
Background:Effects of caloric supplementation on the graft function after deceased donor liver transplantation(DDLT) have not been investigated much.The authors investigated the correlation between th
会议
Interactions between engineered HBV-specific T cells and hepatocellular carcinoma cells in a 3D micr
Background:Hepatocellular carcinoma(HCC) cells often have hepatitis B virus(HBV)-DNA integration and can be targeted by T cells engineered to express HBV-specific T-cell receptors(TCR) as a means of t
会议
Analysis of Chronic Hepatitis B Reverse Transcriptase/S variations generated by Nucleoside Analogues
Background:To study the Characteristics of Reverse Transcriptase(RT) and S gene of Chronic Hepatitis B(CHB) patients generated by Nucleoside Analogues resistance.
会议
Entecavir maleate versus Entecavir in Chinese patients with HBeAg-negative Chronic Hepatitis B:Resul
Background:Entecavir is guanosine analogue with significant activity against HBV.Entecavir maleate is a derivation of entecavir and had been approved by SFDA(State Food and Drug Administration of Chin
会议